Mutations in the major peripheral myelin protein zero (PO) gene on chromosome Iq21-q23 have been found with the hereditary demyelinating polyneuropathy Char co t-Marie-Tooth type IB. Here, we describe 2 patients with distinct neurological characteristics, carrying differ ent substitutions at the saíne codon-Arg69His and Arg-69Cys. The patients were heterozygous for the mutation3 which in both appeared to be de novo. Histological exam ination of sural nerve biopsy specimens revealed defective myelin as well as marked differences, confirming the im portance of PO in the compaction of myelin.
Charcot-Marie-Tooth type 1 (CMT1 or hereditary motor and sensory neuropathy [HMSN] type I) is the most frequently inherited, autosomal dominant, demy elinating polyneuropathy and appears to be genetically heterogeneous [1] , The locus for CMT1A, the most common form, maps to chromosome 17p 11.2 and is usually associated with a DNA duplication of 1.5 Mb encompassing the peripheral myelin protein 22 (PMP22) gene. Single-base mutations in the PMP22 gene have been reported in a f CMT1A cases [1, 2J.
Alterations in the major peripheral myelin protein zero (PO) gene, localized on chromosome Iq21-q23, have been shown to cause CMT1B [1, 31 and have also been found in patients with sporadic early-onset disease with a more severe phenotype, also known as Dejerine-Sottas syndrome [4] .
P0 is a 28-kd integral membrane glycoprotein en coded by 6 exons. It belongs to the immunoglobulin superfamily, having a single extracellular domain re sembling the immunoglobulin variable domain. In ad dition, P0 contains single transmembrane and cyto plasmic domains [5] . A role for P0 in myelin formation has been demonstrated by the analysis of mice lacking P0 expression due to targeted mutagenesis [6] . Since the extracellular domain (encoded by exons 2 and 3) is capable of homophilic interaction, P0 presumably plays a role in the compaction of peripheral myelin m.
We performed a mutation screening of the PO gene in unrelated CM T patients, already characterized as non-CM TlA, by single-stranded conformational anal ysis (SSCA) followed by sequencing of the relevant DNA region. To study the effect of P0 mutations on myelin compaction, we also performed electron micro scopic examinations on sural nerve biopsy specimens from the patients.
Materials and Methods
Patients CMT1 patients were identified on the basis of neurological abnormalities and markedly reduced nerve conduction. Pa tients had already been analyzed for the presence of the CMT1A duplication and screened for mutations in the PMP22 gene. With informed consent, sural nerve biopsy samples were taken from the patients and examined by light and electron microscopy.
Patient 1, a 28-year-old woman, had normal early devel opment. From the age of 2 years onward, motor perfor mances slowly deteriorated. Neurological examination at age 12 years revealed pes cavus, distal muscular weakness and atrophy of the lower legs and the hands, slight distal sensory loss, and nearly absent tendon reflexes. Motor nerve conduc tion velocity (MNCV) of the median nerve was 19 m/sec. Sural nerve biopsy was performed. In the following years her condition hardly deteriorated. The patient carried a Arg69His substitution in exon 3 of the PO gene (see Results).
Patient 2, a girl, had normal development until the age of 6 months. Motor development then stopped and she dete riorated after the age of 10 months. At 14 months, she had an extreme head lag, had difficulties coughing, choked, and cried without sound. She did not roll over nor did she push herself up anymore. The arms and legs were weak and flaccid with areflexia. Sural nerve biopsy was performed. She died at the age of 22 months. M NCV in the ulnar nerve was 8.5 m/sec. She carried a Arg69Cys substitution in exon 3 of the PO gene (see Results).
Mutation Detection
Genomic DNA was isolated from leukocytes according to standard procedures. Primers were chosen according to pub-lished PO exonic and in tronie sequences [5]: primers (5*-30-P0ex2Rl CTGAGACCCACTCACTGGAC; P0ex2F2 AGGTCCATGGTGCTGTGG; P0ex2R2 TTATCGAACC CCAGGATTCC; P0ex3Fl AGGGTCCTCTCACATGC TTC; P0ex3Rl AG G T T G T GT AT G ACAAT G G AG C ; and P0ex3F2 TG G CTC C ATT G TC AT AC AC A. Primers A to F described by Hayasaka and colleagues [8] were also used. SSCAs were carried out essentially as described by Nicholson and coauthors [9] . For analysis of the separate alleles, the SSCA fragments were cut out of the gel and eluted in 100 |il of sterile water. After three cycles of freezing (liquid nitro gen) and thawing (65°C), 5 JLll was used in a 50-J.ll standard polymerase chain reaction (PCR) for sequencing. PCR prod ucts for sequencing were also generated from genomic DNA (100 ng). Products were column purified (Qiagen) and 50 ng was directly sequenced using the dideoxy chain termination method with the Sequitherm Cycle Sequencing Kit (Epi centre Technologies) and ^P-end-labeled P0 primers. Sam ples were electrophoresed on 7% denaturing polyacrylamide Nucleotide numbering of P0 starts at the initiation site of translation. Amino acid numbering starts at the first amino acid (lie) of the mature P0 protein (without the 29 amino acids from the signal peptide) [ 10].
Light and Electron Microscopy
Sural ne I've biopsy specimens were prepared for light and electron microscopic examination including morphometric analysis. For ultrastructural analysis nerve specimens were fixed immediately in 2% glutaraldehyde in 0.1 M cacodylate buffer, pH 7.4, at 4°C for 3 hours and postfixed in 2% osmium tetroxide, pH 7.4, for 1 hour, dehydrated in alcohol, and embedded in epoxy resin (Epon). More than 1,000 nerve biopsy specimens were analyzed this way, including from more than 100 patients with HMSN [11].
Results

Mutations
We analyzed the PO gene for the presence of mutations using SSCA and direct sequencing. Patient 1 carried a G-to-A mutation at position 293, leading to an amino acid substitution of Arg to His at codon 69 (the same mutation was found in another CMT1B patient [12] ). The Arg69His mutation appeared to be absent from exon 3 of both clinically normal parents, demonstrat ing the de novo origin of the substitution. Another de novo base change (C to T at position in the severely affected patient (Patient 2), re sulting in an amino acid substitution of Arg by Cys at the same codon 69. The patients were heterozygous for the mutant and the normal allele. Paternity was confirmed for both patients. Furthermore, the entire coding region of the PO gene of the patients was se quenced and revealed no further mutations.
was
Light and Electron Microscopy
Sural nerve biopsy fro m patients showed a marked reduction in density of myelinated
.'.i fibers. Patient 1 (Fig 1) had 6,010 and Patient 2 7,200 fibers/mnr, corresponding to 57% and 46% of the age-related values, respectively. In Patient 1, largediameter fibers (> 6.5 f.lm) were totally lacking; most fibers were thinly myelinated and surrounded by onion bulbs of concentrically arranged Schwann cell lamellae. By ultrastructural examination of cross sections, the vast majority of fibers (80%) showed uncompacted my elin lamellae, which in some cases (> 12%) could not be discerned from a Schmidt-Lanter man incisure. The uncompacted structure was present over the whole or part of the circumference of the fiber and commonly involved the inner lamellae, but occasionally the outer lamellae as well. Dilatation of the major dense line was most pronounced, with often changing amounts o Schwann cell cytoplasm in between. Partial fusion of intraperiod lines was observed on occasional fibers.
On the other hand, Patient 2 showed only few on ion bulbs, clearly coo-thin myelin sheaths in compari son with axon diameter, and almost no large fibers (2% > 6 |am, 0%) > 8 (.Lm). Increased neurofilamenr accuin demyelinated axons. On . The PO extracellular domain contains a nonasaccharide that is N-linked to Asn93 and two cysteines at positions 21 and 98. Both P0 molecules in the homophilic pair have to be glycosyl ated for adhesion to take place [13] . The cysteines form a disulfide bond that is essential to the functioning of P0 as an adhesion molecule [14] . The cytoplasmic do main of P0 is thought to interact with a component of the opposing membrane in compact myelin, thereby holding these membranes together at the major dense line [15] .
Recently, a molecular model of the P0 extracellular domain was described [16] . According to this model, Arg69 is postulated to be on putative ß-strand 6 of the P0 extracellular domain. This residue is predicted to be essential for complementary electrostatic interac tions from apposed membranes and may also be in volved in the protein-carbohydrate interaction at the base of the molecule [17] . Substitution of this residue with cysteine probably results in inappropriate forma tion of either intramolecular or intermolecular disulfide bonds, whereas Arg69His most likely leads to disrupted P0-P0 interactions through steric hindrance or changes in electrostatic interactions, or both, all leading to de fective myelin [17] . On the other hand, both muta tions also might lead to deleterious conformational changes or disrupt the P0 extracellular domain-carbo hydrate link.
In support of this hypothesis, the histological exami nations of sural nerve biopsy specimens showed defec tive compaction of myelin (see Fig) . Although in sev eral instances the uncompacted myelin structure might be ascribed to Schmidt-Landerman incisures, the over all frequency on cross sections (80% in Patient 1, 43% in Patient 2) markedly surpassed the frequency of Schmidt-Lanterman incisures in normal sural nerves (0-5.5%, n = 3) or in nerves from patients with ge netically unspecified, demyelinating HM SN (^ 9%, n = 9) [18] . In both patients wide spacing of myelin layers was seen most frequently at the inner layers of the sheath. Patient 2 with Arg69Cys showed an in crease in neurofilament density of demyelinated axons, a feature sometimes seen in demyelinated axons in hu man or animal pathology [11, 19] . Family analysis showed that both Arg69 substitutions were de novo mutations, underlining the role of P0 in the pathogen esis of C M TlB . Neuropsychological functioning and brain magnetic resonance imaging (MRI) were evaluated in 84 men with adrenomyeloneuropathy (AMN). MRI was normal in 61%, the "pure AMN" group, while 39%, the "cerebral AMN" group, showetl brain white matter abnormalities. Except for mild deficits in psychomotor speed and visual memoiy, neuropsychological function was normal in pure AMN. Most patients with cerebral AMN had normal IQ and language but evidenced impaired psychomotor speed, spatial cognition, memory, and executive functions. Pa tients with MRI evidence o f very severe cerebral disease had global and language impairment as well, and deficits in all patients were highly correlated with degree o f brain MRI involvement.
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Ann Neurol 1996;40:675-678 X-linked adrenoleukodystrophy (ALD) [1] presents in childhood as a rapidly dementing illness with a charac teristic pattern of demyelination demonstrable by mag netic resonance imaging (MRI) [2]. In adulthood, it presents most commonly as a slowly progressive para paresis associated with degeneration of the long tracts in the spinal cord [2], which is referred to as adreno myeloneuropathy (AMN). While, in comparison with childhood ALD cerebral function in AMN is well pre served, we have shown previously that some AMN pa tients develop subcorcical dementia [3], and 45% have white matter abnormalities demonstrable by MRI [4]. This report correlates neuropsychological function and brain MRI in AMN patients.
